BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260721
DTEND;VALUE=DATE:20260724
DTSTAMP:20260515T001417
CREATED:20260326T113151Z
LAST-MODIFIED:20260326T113151Z
UID:43220-1784592000-1784851199@www.pharmajournalist.com
SUMMARY:6th Medical Device Software Development Summit
DESCRIPTION:The 6th Medical Device Software Development Summit returns this July in Boston and brings together the specialists who are defining how AI-driven and software-based medical devices are built\, validated\, and submitted in an increasingly complex regulatory environment. \nAI is accelerating innovation faster than traditional compliance models can keep up. FDA expectations for AI-enabled devices continue to evolve\, cybersecurity scrutiny is intensifying\, and global regulations such as the EU AI Act are adding new layers of complexity. The summit provides the clarity needed to navigate this shift by focusing on the real-world application of AI\, automation\, model development\, and lifecycle management in regulated device environments. \nAcross three days of technical sessions and workshops\, you will learn how leading teams are integrating AI responsibly\, reducing regulatory risk\, and strengthening product development pipelines. Speakers will break down practical frameworks for safe and compliant AI integration\, including model validation\, data quality\, transparency expectations\, documentation strategies\, and global submission planning. Sessions also explore how continuous deployment and code generation tools can be aligned with compliance requirements. \nYou will: \n\nGain clear insight into evolving FDA expectations for AI-enabled and learning devices\nLearn best practices for AI model development\, validation\, and deployment across the product lifecycle\nExplore cybersecurity architectures that protect AI-driven systems from emerging risks\nUnderstand how companies are modernizing development workflows through automation and AI-assisted engineering while maintaining compliance\nBenchmark with software\, regulatory\, quality\, cybersecurity\, and product leaders who openly share real-world implementations and lessons\n\nWith a focused senior-level audience\, discussions are practical\, detailed\, and grounded in real use cases instead of high-level theory. If your team is building or validating AI-enabled medical device software in 2026\, this summit is the most concentrated source of guidance on how to innovate safely\, accelerate approvals\, and future-proof your roadmap in a rapidly shifting landscape. \nJoin the community leading the next generation of AI-driven medical device software and gain the insight and tools needed to advance your program with confidence. \nTo learn more and register online\, please click here.
URL:https://www.pharmajournalist.com/event/6th-medical-device-software-development-summit/
LOCATION:Hotel AKA Back Bay\, 154 Berkeley St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260721
DTEND;VALUE=DATE:20260724
DTSTAMP:20260515T001417
CREATED:20260430T111342Z
LAST-MODIFIED:20260430T111342Z
UID:43429-1784592000-1784851199@www.pharmajournalist.com
SUMMARY:9th International Neoantigen Summit
DESCRIPTION:As the only conference focused on neoantigens\, the 9th International Neoantigen Summit returns to Amsterdam as the most timely and essential gathering for the field. As your only chance this year to learn about the latest clinical data in the field and address the full translational journey – from antigen identification and validation through to biomarker strategy\, clinical trial readouts and therapeutic efficacy – it’s not one to miss. \nWith a sharp focus on optimising translational testing\, strengthening neoantigen validation and advancing novel personalised and off‑the‑shelf approaches\, the conference is designed to help the industry streamline clinical trials and develop durable therapies with high immune response. \nOver 3 immersive days\, the summit will unite 70+ C‑level executives\, directors\, heads and senior scientists from leading biopharma organisations across Europe and the US. Attendees span: \n\nCancer immunotherapy\nAntigen discovery\nBioinformatics\nAI‑driven validation\nPreclinical and clinical development\nRegulatory strategy\n\nAll brought together by a shared mission to unlock the full potential of neoantigen‑targeted therapies. \nWith 6 new speaking companies\, including Black Canyon Bio\, CellVax Therapeutics\, Echo Immune\, Epitopea\, Khosen Bio and Treos Bio\, the summit convenes industry pioneers including Nykode Therapeutics\, Evaxion\, Geneos\, and other leading innovators shaping the next generation of immunotherapies. Every session is curated for relevance\, and every interaction is designed to foster meaningful collaboration. \nParticipants can expect critical clinical data updates\, practical insights into bioinformatics and AI applications\, strategies for clinical trial design and execution\, and guidance on translating preclinical findings into successful clinical outcomes. More than a conference\, this is the only annual checkpoint for the neoantigen community – a one‑stop platform to benchmark progress\, uncover breakthroughs and build the partnerships that will drive the next wave of neoantigen‑targeted therapies forward.
URL:https://www.pharmajournalist.com/event/9th-international-neoantigen-summit/
LOCATION:Park Plaza Amsterdam Victoria\, Damrak 1-5\, 1012 LG\, Amsterdam\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR